CRADS Calculator v. 2023

ACR's CT Colonography Imaging Reporting & Data System (C-RADS ™), for describing colorectal and extra-colonic findings - Version 2023 (released January 2024)

Colonic study status *

Extracolonic assessment (Optional)
Complete the required colonic assessment to see the result.
Click here to see the missing fields ⌕

ACR C-RADS Calculator for colonic findings on CT Colonography

More about the C-RADS® Calculator

The CT Colonography Reporting and Data System (C‑RADS®), endorsed by the American College of Radiology (ACR), is a standardized framework designed to streamline the classification of findings from CT colonography (CTC). Since its initial release in 2005, C‑RADS has been instrumental in enhancing consistency, clarity, and clinical decision-making for both colonic and extracolonic observations. The 2023 update brings important refinements to the system, further optimizing its utility for radiologists and referring clinicians.

Key Updates in the 2023 C‑RADS Version

  • Introduction of C2b Subcategory: This new classification identifies mass-like diverticular strictures that visually resemble polyps but are commonly benign. This differentiation helps minimize unnecessary colonoscopies.
  • Extracolonic Category Consolidation: E1 and E2 have been merged into a unified E1/E2 category, reflecting the clinical understanding that neither warrants additional imaging or follow-up.

C‑RADS® Colon Categories and Recommended Actions

  • C0: Incomplete or technically inadequate CTC — repeat imaging is recommended.
  • C1: Normal colon or findings considered unequivocally benign — standard interval screening applies.
  • C2a: Indeterminate 6-9 mm polyps — recommend either short-term follow-up CTC or colonoscopy.
  • C2b: Mass-like but likely benign strictures — further evaluation with targeted follow-up may be appropriate.
  • C3: Lesions suggestive of advanced adenomas — diagnostic colonoscopy advised.
  • C4: Highly suspicious findings, such as masses — urgent colonoscopy and further management warranted.

Extracolonic Findings Classification

Extracolonic observations are sorted into categories based on their clinical relevance. E1/E2 covers benign or incidental findings that typically require no further evaluation. In contrast, E3 includes potentially significant anomalies, and E4 reflects findings that may require prompt investigation due to possible serious implications.

Clinical Benefits and Workflow Efficiency

  • Standardized Reporting: Adherence to ACR-approved guidelines enhances clarity and reduces subjective variability in radiology reports [1].
  • Optimized Patient Care: Structured classifications help avoid unnecessary invasive testing and guide appropriate follow-up pathways.
  • Risk Stratification: Differentiation between benign, indeterminate, and high-risk lesions supports better shared decision-making.
  • Data Uniformity: The system’s consistent language facilitates quality assurance, research standardization, and benchmarking efforts [2].

How to Use the CRADS 2023 Calculator

The calculator allows radiologists to input polyp size, location, morphology, and extracolonic findings to automatically generate the appropriate C‑RADS category. The output includes:

  • Category assignment aligned with 2023 ACR recommendations
  • Built-in follow-up suggestions, such as surveillance timelines for C2a lesions
  • Templates for inclusion in radiology reports or EMR documentation

The C‑RADS® 2023 update introduces strategic refinements that improve diagnostic precision and enhance communication among multidisciplinary teams. With simplified extracolonic categories and a new polyp subcategory, the updated system helps radiologists offer patient-centered, evidence-based care while minimizing ambiguity in colorectal cancer screening protocols.

 
Dr. Pooyan Khalighinejad
Reviewed by Pooyan Khalighinejad, M.D.
Radiologist and Nuclear Medicine Specialist
Neuroradiology fellow at Johns Hopkins University
UT Southwestern Medical Center alumnus

Share your thoughts

Rate this page:
★ ★ ★ ★ ★
Be the first to rate!

Your email address will not be published. Required fields are marked *